Malignant Pleural Mesothelioma, Biphasic Type: An Unusual and Insidious Case of Rapidly Progressive Small Blue Cell Tumor

被引:2
作者
Salazar, Carlos [1 ]
Kanter, Nelson [2 ]
Abboud, Amer [3 ]
机构
[1] Louis A Weiss Mem Hosp, Dept Internal Med, Chicago, IL 60640 USA
[2] Louis A Weiss Mem Hosp, Dept Pulm & Crit Care Med, Chicago, IL USA
[3] Louis A Weiss Mem Hosp, Dept Pathol, Chicago, IL USA
来源
CUREUS | 2018年 / 10卷 / 06期
关键词
malignant pleural mesothelioma; asbestos;
D O I
10.7759/cureus.2749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant pleural mesothelioma (MPM) is a rare neoplasm. It predominantly affects elderly individuals aged over 70 years presenting with a unilateral pleural tumor usually associated with previous asbestos exposure. The respiratory symptoms are associated with ipsilateral pleural involvement with concomitant pleural effusions. The diagnosis of MPM is established by the morphologic and immunohistochemical features of a cytologic specimen. MPM can present as three histologic subtypes: epithelioid, sarcomatoid, or biphasic. We present a case of an 85-year-old Caucasian female with a history of occupational asbestos exposure. She complained of 1-week history of progressive sharp right flank and scapular pain with mild shortness of breath, dry cough and pleuritic chest pain. CT of the chest showed a large loculated right pleural effusion with adjacent pleural thickening. CT abdomen and pelvis was negative for other neoplastic findings. CT-guided core biopsy of the right pleural-based mass was positive for a spindle to plasmacytoid small blue cell tumor. An extensive immunohistochemical panel was non-specific. A focal OSCAR keratin and WT-1 expression in the absence of carcinoma markers, a malignant mesothelioma, biphasic type was diagnosed. Further workup with PET-CT and cytotoxic chemotherapy combined with immunotherapy or tyrosine kinase inhibitors was recommended by oncology. The patient refused further imaging and treatment, and palliative care was consulted.
引用
收藏
页数:7
相关论文
共 19 条
[1]  
Allen TC, 2005, ARCH PATHOL LAB MED, V129, P1415
[2]   Glypican-1 immunohistochemistry is a novel marker to differentiate epithelioid mesothelioma from lung adenocarcinoma [J].
Amatya, Vishwa Jeet ;
Kushitani, Kei ;
Kai, Yuichiro ;
Suzuki, Rui ;
Miyata, Yoshihiro ;
Okada, Morihito ;
Takeshima, Yukio .
MODERN PATHOLOGY, 2018, 31 (05) :809-815
[3]   Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival [J].
Baumann, Francine ;
Flores, Erin ;
Napolitano, Andrea ;
Kanodia, Shreya ;
Taioli, Emanuela ;
Pass, Harvey ;
Yang, Haining ;
Carbone, Michele .
CARCINOGENESIS, 2015, 36 (01) :76-81
[4]   Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment [J].
Bibby, Anna C. ;
Tsim, Selina ;
Kanellakis, Nikolaos ;
Ball, Hannah ;
Talbot, Denis C. ;
Blyth, Kevin G. ;
Maskell, Nick A. ;
Psallidas, Ioannis .
EUROPEAN RESPIRATORY REVIEW, 2016, 25 (142) :472-486
[5]   Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008 [J].
Delgermaa, Vanya ;
Takahashi, Ken ;
Park, Eun-Kee ;
Le, Giang Vinh ;
Hara, Toshiyuki ;
Sorahan, Tom .
BULLETIN OF THE WORLD HEALTH ORGANIZATION, 2011, 89 (10) :716-724
[6]   The global burden of-disease due to occupational carcinogens [J].
Driscoll, T ;
Nelson, DI ;
Steenland, K ;
Leigh, J ;
Concha-Barrientos, M ;
Fingerhut, M ;
Prüss-Üstün, A .
AMERICAN JOURNAL OF INDUSTRIAL MEDICINE, 2005, 48 (06) :419-431
[7]   The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM [J].
Edge, Stephen B. ;
Compton, Carolyn C. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (06) :1471-1474
[8]   Identification of ALK Rearrangements in Malignant Peritoneal Mesothelioma [J].
Hung, Yin P. ;
Dong, Fei ;
Watkins, Jaclyn C. ;
Nardi, Valentina ;
Bueno, Raphael ;
Dal Cin, Paola ;
Godleski, John J. ;
Crum, Christopher P. ;
Chirieac, Lucian R. .
JAMA ONCOLOGY, 2018, 4 (02) :235-238
[9]   Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group [J].
Husain, Aliya N. ;
Colby, Thomas ;
Ordonez, Nelson ;
Krausz, Thomas ;
Attanoos, Richard ;
Beasley, Mary Beth ;
Borczuk, Alain C. ;
Butnor, Kelly ;
Cagle, Philip T. ;
Chirieac, Lucian R. ;
Churg, Andrew ;
Dacic, Sanja ;
Fraire, Armando ;
Galateau-Salle, Francoise ;
Gibbs, Allen ;
Gown, Allen ;
Hammar, Samuel ;
Litzky, Leslie ;
Marchevsky, Alberto M. ;
Nicholson, Andrew G. ;
Roggli, Victor ;
Travis, William D. ;
Wick, Mark .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (05) :647-667
[10]   Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group [J].
Husain, Aliya Noor ;
Colby, Thomas V. ;
Ordonez, Nelson G. ;
Allen, Timothy Craig ;
Attanoos, Richard Luther ;
Beasley, Mary Beth ;
Butnor, Kelly Jo ;
Chirieac, Lucian R. ;
Churg, Andrew M. ;
Dacic, Sanja ;
Galateau-Salle, Francoise ;
Gibbs, Allen ;
Gown, Allen M. ;
Krausz, Thomas ;
Litzky, Leslie Anne ;
Marchevsky, Alberto ;
Nicholson, Andrew G. ;
Roggli, Victor Louis ;
Sharma, Anupama K. ;
Travis, William D. ;
Walts, Ann E. ;
Wick, Mark R. .
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2018, 142 (01) :89-108